MediciNova, Inc. (4875.T)
JPY 213.0
(-3.18%)
JPY 213.0
(-3.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1 Million | - | 4.03 Million | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | 1 Million | - | 4.03 Million | - | - |
| Operating Expenses | 10.9 Million | 14.62 Million | 14.25 Million | 14.17 Million | 14.03 Million |
| Selling, General and Administrative Expenses | 5.24 Million | 5.48 Million | 5.71 Million | 6.69 Million | 7.95 Million |
| Research and Development Expenses | 5.65 Million | 9.14 Million | 8.53 Million | 7.48 Million | 5.73 Million |
| Other Expenses | - | -247.28 Thousand | -59.49 Thousand | -38.4 Thousand | 345 Thousand |
| Cost and Expenses | 10.9 Million | 14.62 Million | 14.25 Million | 14.17 Million | 14.03 Million |
| Operating Income | -9.9 Million | -14.62 Million | -10.21 Million | -14.17 Million | -14.03 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | 3047.00 | 2822.00 | 2568.00 | -1648.00 | 12.66 Thousand |
| Earnings before Tax | -8.56 Million | -14.06 Million | -10.13 Million | -13.85 Million | -12.92 Million |
| Net Income | -8.57 Million | -1.85 Billion | -1.17 Billion | -1.43 Billion | -12.94 Million |
| Earnings Per Share Basic | -0.17 | -37.63 | -24.00 | -32.20 | -0.30 |
| Earnings Per Share Diluted | -0.17 | -37.63 | -24.00 | -32.20 | -0.30 |
| Weighted Average Shares Outstanding | 49.04 Million | 49.16 Million | 48.75 Million | 44.4 Million | 43.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.04 Million | 49.16 Million | 48.75 Million | 44.4 Million | 43.15 Million |
| Gross Margin | 1.00 | - | 1.00 | - | - |
| EBIT Margin | -9.88 | - | -2.52 | - | - |
| Profit Margin | -8.57 | - | -289.78 | - | - |
| EBITDA | -9.87 Million | -14.61 Million | -10.18 Million | -14.15 Million | -14 Million |
| Earnings Before Tax Margin | -9.90 | - | -2.53 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 1 Million | 1 Million | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | 1 Million | 1 Million | - |
| Operating Expenses | 3.04 Million | 3.13 Million | 2.49 Million | 10.9 Million | 2.14 Million | 3.3 Million |
| Selling, General and Administrative Expenses | 1.4 Million | 1.35 Million | 839.32 Thousand | - | 1.35 Million | 1.56 Million |
| Research and Development Expenses | 1.64 Million | 1.78 Million | 1.65 Million | - | 794.7 Thousand | 1.73 Million |
| Other Expenses | -17.05 Thousand | -16.03 Thousand | -2199.00 | -502.86 Thousand | -14.15 Thousand | -23.21 Thousand |
| Cost and Expenses | 3.04 Million | 3.13 Million | 2.49 Million | 10.9 Million | 2.14 Million | 3.3 Million |
| Operating Income | -3.04 Million | -3.13 Million | -2.49 Million | -9.9 Million | -1.14 Million | -3.3 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -435.35 Thousand | -397.51 Thousand | -433.21 Thousand | 3047.00 | -437.93 Thousand | -451.42 Thousand |
| Earnings before Tax | -2.62 Million | -2.75 Million | -2.05 Million | -8.56 Million | -723.1 Thousand | -2.87 Million |
| Net Income | -2.62 Million | -416.91 Million | -290.54 Million | -1.21 Billion | -108.06 Million | -414.52 Million |
| Earnings Per Share Basic | -0.05 | -8.51 | -5.93 | - | -2.20 | -8.46 |
| Earnings Per Share Diluted | -0.05 | -8.51 | -5.93 | - | -2.20 | -8.46 |
| Weighted Average Shares Outstanding | 49.04 Million | 48.99 Million | 48.99 Million | 49.06 Million | 49.11 Million | 48.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.04 Million | 48.99 Million | 48.99 Million | 49.06 Million | 49.11 Million | 48.99 Million |
| Gross Margin | - | - | - | 1.00 | 1.00 | - |
| EBIT Margin | - | - | - | - | -1.14 | - |
| Profit Margin | - | - | - | -1210.00 | -108.06 | - |
| EBITDA | -3.04 Million | -3.13 Million | -2.48 Million | - | -1.14 Million | -3.29 Million |
| Earnings Before Tax Margin | - | - | - | -9.90 | -1.15 | - |
6485
FROG
4004
4577
9790
0K9J